InPlay: Biodel advances ultra-rapid-acting concentrated insulin formulation into clinical developmentNov 7
DANBURY, Conn. -- Biodel Inc. today announced the initiation of a Phase 1 clinical trial under its existing U.S. Investigational New Drug Application, as part of the development program for concentrated ...
Unilife is no stranger to making promises, but profitability eludes the company. Should investors believe that its collaborations with Sanofi and Biodel will boost its top line exponentially?
Investors in Biodel Inc saw new options become available today, for the January 2014 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 124 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Biodel Inc. announced initial results from a phase II study evaluating its candidate, BIOD-123.
Errol De Souza Thank you, Paul. Good morning everyone and thank you for joining us to review some very exciting data from our Phase 2 study of BIOD-123 versus Humalog. Following the complete response letter ...